T&R Biofab Past Earnings Performance
Past criteria checks 0/6
T&R Biofab has been growing earnings at an average annual rate of 42.8%, while the Medical Equipment industry saw earnings growing at 22.8% annually. Revenues have been declining at an average rate of 6.3% per year.
Key information
42.8%
Earnings growth rate
43.7%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | -6.3% |
| Return on equity | -28.9% |
| Net Margin | -157.6% |
| Last Earnings Update | 31 Dec 2024 |
Recent past performance updates
No updates
Recent updates
Is T&R Biofab (KOSDAQ:246710) Using Too Much Debt?
Feb 18
Is T&R Biofab (KOSDAQ:246710) Using Debt Sensibly?
Feb 26Do Insiders Own Lots Of Shares In T&R Biofab Co., Ltd. (KOSDAQ:246710)?
Mar 09Can You Imagine How T&R Biofab's (KOSDAQ:246710) Shareholders Feel About The 65% Share Price Increase?
Jan 12
Do Institutions Own T&R Biofab Co., Ltd. (KOSDAQ:246710) Shares?
Nov 18Revenue & Expenses Breakdown
How T&R Biofab makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 24 | 4,874 | -7,679 | 8,022 | 5,510 |
| 31 Dec 23 | 5,199 | -13,419 | 7,695 | 4,399 |
Quality Earnings: A246710 is currently unprofitable.
Growing Profit Margin: A246710 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if A246710's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare A246710's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A246710 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.2%).
Return on Equity
High ROE: A246710 has a negative Return on Equity (-28.92%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/04 21:04 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
T&R Biofab Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pyeongkuk Park | NH Investment & Securities Co., Ltd. |